XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Millions
Total
Cumulative adjustment for adoption new accounting standard
Common Stock
Common Stock
Unvested restricted stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative adjustment for adoption new accounting standard
Accumulated Other Comprehensive Loss
Temporary equity, beginning balance (in shares) at Dec. 31, 2019 209,608,075                
Temporary equity, beginning balance at Dec. 31, 2019 $ 447                
Convertible Preferred Preferred Stock                  
Redemption of Series B preferred stock (in shares) (77,270)                
Issuance of preferred stock (in shares) 44,301,220                
Issuance of preferred stock $ 403                
Issuance cost of Series F preferred stock $ (1)                
Temporary equity, ending balance (in shares) at Dec. 31, 2020 253,832,025                
Temporary equity, ending balance at Dec. 31, 2020 $ 849                
Beginning balance (in shares) at Dec. 31, 2019     214,901,400            
Beginning balance at Dec. 31, 2019 (330) $ 18 $ 0   $ 0 $ 56 $ (386) $ 18 $ 0
Beginning balance (in shares) at Dec. 31, 2019         200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock (in shares)     (1,011,880)            
Common stock repurchased (in shares)         25,000        
Redemption of Series B preferred stock (1)         (1)      
Issuance of common stock upon exercise of common stock options (in shares)     5,865,910            
Issuance of common stock upon exercise of common stock options 4         4      
Stock-based compensation expense 86         86      
Unrealized loss on marketable securities 0                
Net loss (248)           (248)    
Ending balance (in shares) at Dec. 31, 2020     219,755,430            
Ending balance at Dec. 31, 2020 $ (471) $ 1 $ 0   $ 0 145 (616) $ 1 0
Ending balance (in shares) at Dec. 31, 2020         225,000        
Convertible Preferred Preferred Stock                  
Conversion of preferred stock (in shares) (253,832,025)                
Conversion of preferred stock $ (849)                
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares)     25,000,000            
Issuance of common stock in connection with initial public offering, net of offering costs $ 944         944      
Temporary equity, ending balance (in shares) at Dec. 31, 2021 0                
Temporary equity, ending balance at Dec. 31, 2021 $ 0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock (in shares)     (35,665)            
Issuance of common stock upon net exercise of common stock warrants (in shares)     1,140,931            
Issuance of common stock upon net exercise of common stock warrants 56         56      
Conversion of preferred stock (in shares)     253,832,025            
Conversion of preferred stock 849         849      
Issuance of common stock upon exercise of common stock options (in shares)     6,307,785            
Issuance of common stock upon exercise of common stock options 7         7      
Exercise of common stock options in connection with promissory notes repayment 14         14      
Issuance of common stock upon vesting of restricted stock units (in shares)     53,570            
Stock-based compensation expense [1] 141         141      
Vesting of restricted stock 4         4      
Issuance of common stock in connection with business combination (in shares)     569,400            
Issuance of common stock in connection with business combination 15         15      
Charitable contribution stock-based expense (in shares)     546,889            
Charitable contribution stock-based expense 19         19      
Unrealized loss on marketable securities (1)               (1)
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares)     25,000,000            
Issuance of common stock in connection with initial public offering, net of offering costs 944         944      
Net loss (487)           (487)    
Ending balance (in shares) at Dec. 31, 2021     507,170,365            
Ending balance at Dec. 31, 2021 $ 1,091   $ 0   $ 0 2,194 (1,102)   (1)
Ending balance (in shares) at Dec. 31, 2021 225,000       225,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock (in shares)     (33,475)            
Issuance of common stock upon net exercise of common stock warrants (in shares)     371,573            
Issuance of common stock upon net exercise of common stock warrants $ 18         18      
Issuance of common stock upon exercise of common stock options (in shares) 7,633,661   7,633,661            
Issuance of common stock upon exercise of common stock options $ 15         15      
Issuance of common stock upon vesting of restricted stock units (in shares)     5,962,878            
Stock-based compensation expense 235         235      
Vesting of restricted stock 4         4      
Issuance of common stock in connection with business combination (in shares)     37,179 1,338,228          
Issuance of common stock in connection with business combination 1         1      
Charitable contribution stock-based expense (in shares)     546,889            
Charitable contribution stock-based expense 10         10      
Unrealized loss on marketable securities (1)               (1)
Cumulative translation adjustment 0               0
Net loss (275)           (275)    
Ending balance (in shares) at Dec. 31, 2022     523,027,298            
Ending balance at Dec. 31, 2022 $ 1,098   $ 0   $ 0 $ 2,477 $ (1,377)   $ (2)
Ending balance (in shares) at Dec. 31, 2022 225,000       225,000        
[1] During the year ended December 31, 2021, stock-based compensation expense recorded within additional paid-in capital does not include $2 of expense recognized as a result of the acquisition of xtraCHEF due to accelerated vesting of acquiree option awards on the acquisition date (see Note 3, "Business Combinations").